Chembond Material Technologies Ltd
Incorporated in 1974, Chembond Chemicals Ltd manufactures and sells specialty chemicals and animal health products.[1]
- Market Cap ₹ 234 Cr.
- Current Price ₹ 174
- High / Low ₹ 490 / 159
- Stock P/E 16.2
- Book Value ₹ 121
- Dividend Yield 1.00 %
- ROCE 11.5 %
- ROE 10.5 %
- Face Value ₹ 5.00
Pros
- Company is almost debt free.
- Company has been maintaining a healthy dividend payout of 23.8%
- Company's working capital requirements have reduced from 44.6 days to 24.8 days
Cons
- The company has delivered a poor sales growth of -5.54% over past five years.
- Tax rate seems low
- Company has a low return on equity of 6.71% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 274 | 299 | 270 | 291 | 327 | 301 | 268 | 274 | 349 | 440 | 178 | 201 | 221 | |
| 253 | 273 | 259 | 274 | 304 | 275 | 258 | 256 | 332 | 405 | 172 | 188 | 206 | |
| Operating Profit | 21 | 26 | 11 | 17 | 23 | 26 | 10 | 18 | 17 | 35 | 7 | 14 | 15 |
| OPM % | 8% | 9% | 4% | 6% | 7% | 8% | 4% | 7% | 5% | 8% | 4% | 7% | 7% |
| 1 | 1 | 189 | 18 | 11 | 4 | 3 | 15 | 9 | 5 | 14 | 9 | 5 | |
| Interest | 4 | 4 | 2 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 0 |
| Depreciation | 3 | 4 | 4 | 4 | 4 | 4 | 4 | 5 | 4 | 5 | 3 | 3 | 3 |
| Profit before tax | 15 | 20 | 195 | 30 | 28 | 24 | 8 | 29 | 21 | 34 | 17 | 19 | 16 |
| Tax % | 40% | 28% | 20% | 24% | 16% | 19% | 61% | 28% | 32% | 26% | 33% | 10% | |
| 9 | 14 | 156 | 23 | 24 | 20 | 3 | 20 | 14 | 25 | 11 | 18 | 14 | |
| EPS in Rs | 5.76 | 9.24 | 114.66 | 14.43 | 16.40 | 12.93 | 1.40 | 15.18 | 10.39 | 18.73 | 8.34 | 13.10 | 10.77 |
| Dividend Payout % | 26% | 16% | 4% | 11% | 11% | 16% | 144% | 15% | 48% | 16% | 42% | 13% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -4% |
| 5 Years: | -6% |
| 3 Years: | -17% |
| TTM: | -14% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 2% |
| 5 Years: | 54% |
| 3 Years: | 4% |
| TTM: | -42% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 2% |
| 5 Years: | 9% |
| 3 Years: | 5% |
| 1 Year: | -59% |
| Return on Equity | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 6% |
| 3 Years: | 7% |
| Last Year: | 10% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 |
| Reserves | 80 | 89 | 200 | 223 | 242 | 255 | 262 | 286 | 297 | 315 | 137 | 149 | 155 |
| 33 | 25 | 11 | 9 | 9 | 7 | 3 | 2 | 2 | 7 | 7 | 3 | 6 | |
| 86 | 83 | 72 | 82 | 68 | 54 | 50 | 59 | 56 | 74 | 41 | 43 | 44 | |
| Total Liabilities | 205 | 203 | 289 | 321 | 325 | 322 | 322 | 354 | 361 | 402 | 191 | 202 | 211 |
| 54 | 51 | 47 | 49 | 108 | 109 | 124 | 122 | 121 | 116 | 26 | 34 | 41 | |
| CWIP | 3 | 3 | 2 | 2 | 1 | 2 | 0 | 0 | 1 | 12 | 13 | 8 | 1 |
| Investments | 1 | 1 | 88 | 150 | 76 | 58 | 51 | 73 | 75 | 65 | 65 | 78 | 68 |
| 148 | 147 | 152 | 120 | 140 | 153 | 147 | 160 | 165 | 208 | 87 | 83 | 101 | |
| Total Assets | 205 | 203 | 289 | 321 | 325 | 322 | 322 | 354 | 361 | 402 | 191 | 202 | 211 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10 | 24 | -27 | 5 | -12 | -12 | 24 | 25 | -10 | 1 | 94 | 19 | |
| -6 | -3 | 52 | -0 | 19 | 14 | -12 | -11 | -2 | 1 | -89 | -8 | |
| -4 | -18 | -24 | -3 | -4 | -6 | -11 | -2 | -4 | -2 | -5 | -9 | |
| Net Cash Flow | -0 | 3 | 1 | 2 | 3 | -5 | 1 | 12 | -16 | 0 | 0 | 2 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 116 | 105 | 78 | 84 | 90 | 110 | 112 | 111 | 94 | 96 | 100 | 72 |
| Inventory Days | 74 | 60 | 46 | 59 | 46 | 58 | 77 | 82 | 67 | 53 | 58 | 56 |
| Days Payable | 113 | 96 | 86 | 95 | 96 | 84 | 96 | 120 | 76 | 81 | 118 | 113 |
| Cash Conversion Cycle | 77 | 70 | 38 | 49 | 40 | 84 | 94 | 73 | 84 | 67 | 40 | 15 |
| Working Capital Days | 53 | 45 | 90 | 42 | 44 | 82 | 98 | 83 | 78 | 70 | 39 | 25 |
| ROCE % | 15% | 18% | 22% | 12% | 11% | 9% | 3% | 10% | 7% | 10% | 5% | 12% |
Documents
Announcements
- Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 24 Oct
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
19 Oct - Submission of Newspaper advertisement - Unaudited Financial Result of the Company for the quarter and half year ended September 30, 2025.
- Financial Results For Quarter And Half Year Ended September 30, 2025 17 Oct
-
Board Meeting Outcome for Outcome Of Board Meeting
17 Oct - Unaudited consolidated/standalone Q2 results to Sept 30, 2025: consolidated revenue Rs 11,820.21 lakh; limited review.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
16 Oct - Newspaper Advertisement(s) regarding special window for re-lodgement of transfer requests of physical shares
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Business Overview:[1][2]
CCL manufactures specialty chemicals like high-performance coatings, automotive sealants,
metal treatment chemicals, engineering adhesives, vitamins & minerals, probiotics,
and prebiotic enzymes, and feed additives and nutrition products related to animal health, and industrial biotech products.